--2025/Q1-- / 110.839M--
--2024/Q4-- / 98.799M--
Nov 4, 20242024/Q383.879M / 81.705M--
Aug 6, 20242024/Q273.466M / 65.893M--
May 1, 20242024/Q163.474M / 54.608M--
US Stock MarketDetailed Quotes
TGTX TG Therapeutics
- 34.910
- +3.760+12.07%
Trading Nov 21 13:14 ET
5.43BMarket Cap-349100P/E (TTM)
36.400High31.420Low3.37MVolume31.610Open31.150Pre Close115.37MTurnover2.31%Turnover Ratio387.89P/E (Static)155.67MShares36.50052wk High28.29P/B5.09BFloat Cap12.30052wk Low--Dividend TTM145.70MShs Float149414.006Historical High--Div YieldTTM15.99%Amplitude0.956Historical Low34.217Avg Price1Lot Size
TG Therapeutics Key Stats
TG Therapeutics Q3 2024 Earnings Date
Currency：USDNov 4, 2024
| Estimate (YoY) | Actual (YoY) | Vs Estimate (% Chg) | |
| Revenue | 81.70M | 83.88M | +2.17M |
| Beat Est. | -50.73% | -49.41% | +2.66% |
| EPS | 0.03 | 0.02 | -<0.01 |
| Miss Est. | -96.22% | -97.26% | -27.54% |
Analyst Rating
Nov 21, 2024
TG Therapeutics Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
TG Therapeutics Earnings Reports
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data